Incannex Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary

Incannex Healthcare

28/09/2026 13:37

Incannex Healthcare Inc IXHL.OQ reported a quarterly adjusted loss of A$11.23​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of A$-238.98.  The lone analyst forecast for the quarter was for a loss of 75 cents per share. 
Reported revenue was zero​; analysts expected zero. 
Incannex Healthcare Inc's reported EPS for the quarter was a loss of A$12.60​.
The company reported a quarterly loss of A$5.59 million.
Incannex Healthcare Inc shares had fallen by 11.7% this quarter and lost 69.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Incannex Healthcare Inc is $18.00, about 81.6% above its last closing price of $3.32
This summary was machine generated from LSEG data September 28 at 12:37 p.m. UTC. ​All figures in Australian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.93
-0.20
Beat
Mar. 31 2026 
-0.93
-22.83
Missed
Dec. 31 2025 
-0.93
-22.83
Missed
Jun. 30 2025 
-0.93
-22.95
Missed